First Oral Medication News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Interim Data for Potentially the First Oral Medication for PGHD from Phase 2 OraGrowtH210 and PK/PD OraGrowtH212 Trials Met Expectations with an Encouraging Growth Response of 8.6 cm/yr at six. | November 14, 2022

United statesErick hawkinsLisa millerLaura dichtelEli lillyLumos pharmaLumos pharma incEnterprise associatesIowa economic development authorityRoche venture fundBlackstone life sciencesFirst oral medicationMet expectationsEncouraging growth responseSupports advanced planningPivotal phase